Evidence map›Paper›PMID 36077327›Full record

ArticleInternational journal of molecular sciences2022

Glycan-Adhering Lectins and Experimental Evaluation of a Lectin FimH Inhibitor in Enterohemorrhagic

Jun-Young Park, Cheorl-Ho Kim, Seung-Hak Cho

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jun-Young ParkDivision of Zoonotic and Vector Borne Disease Research, Center for Infectious Disease Research, Korea National Institute of Health, Cheongju 28159, Korea.ORCID 0000-0003-3197-3908
Cheorl-Ho KimGlycobiology Unit, Department of Biological Science, Sung Kyunkwan University and Samsung Advanced Institute for Health Science and Technology (SAIHST), Suwon 16419, Korea.ORCID 0000-0002-6323-0714
Seung-Hak ChoDivision of Zoonotic and Vector Borne Disease Research, Center for Infectious Disease Research, Korea National Institute of Health, Cheongju 28159, Korea.
Korea National Institute of Health · KRSamsung (South Korea) · KR

Funding

Korea National Institute of Health NIH 4800-6637-300 to S.H.C.
6 · The paper itself

Abstract

In this study, we tried to develop a FimH inhibitor that inhibits adhesion of enterohemorrhagic

Indexed as

Enterohemorrhagic Escherichia coliEscherichia coli InfectionsEscherichia coli O157Escherichia coli ProteinsAdhesins, Escherichia coliFimbriae ProteinsHumansLectinsPhylogenyPolysaccharidesAdhesins, Escherichia coliEscherichia coli ProteinsFimbriae ProteinsfimH protein, E coliLectinsPolysaccharidesenterohemorrhagic Escherichia coli (EHEC)FimHGb3glycanlectin

Identifiers

PMID36077327
PMCPMC9455959
OpenAlexW4294163278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.